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Context: Anti-neutrophil p-ANCA antibodies are directed against antigens in the peripheral cytoplasm of both neutrophilic 
granulocytes and monocytes. They are detected in several autoimmune disorders and are particularly associated with 
systemic vasculitis. Case Report: We report a case of a 54-year-old female presenting with a pruritic rash, including 
purpura and diffuse erythema. A biopsy with hematoxylin and eosin (H & E) analysis, direct immunofluorescence (DIF), 
immunohistochemistry (IHC) and enzyme-linked immunosorbent assays for ANCAs were performed. The H & E staining 
demonstrated leukocytoclastic vasculitis, with focal vascular fibrinoid necrosis. The DIF revealed evidence of vasculitis, 
the presence of p-ANCAs and neutrophil extracellular traps (NETs). The IHC displayed autoreactivity to myeloperoxidase 
within the vessels. The IHC aided in ruling out any intrinsic autofluorescence of the vessels. Conclusions: By observing 
the deposition of neutrophil extracellular traps and myeloperoxidase in inflamed skin vessels, biopsy analysis may alert 
physicians for rapid therapeutic intervention in patients presenting with possible vasculitides.  
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Anti-neutrophil cytoplasmic antibodies (ANCAs) are a 
group of predominately IgG antibodies, directed against 
antigens in the cytoplasm of both neutrophilic 
granulocytes and monocytes [1]. They are detected in a 
number of autoimmune disorders, but are most often 
associated with forms of systemic vasculitis, the 
ANCA-associated vasculitides [1]. ANCAs were first 
divided into two major classes, c-ANCAs (cytoplasmic) 
and p-ANCAs (or perinuclear), based on their pattern of 
staining inside the affected cells [1]. ANCA titers are 
classically measured using enzyme-linked immunosorbent 
assays (ELISAs), and by indirect immunofluorescence (IIF) 
[1]. As noted, the p-ANCAs display a perinuclear staining 
pattern. The perinuclear pattern occurs because the vast 
majority of the antigens targeted by p-ANCAs are strongly 
cationic (positively charged) at pH 7.00 [1-3]. During 
fixation, the more cationic antigens migrate within the cell 
cytoplasm and congregate around the nucleus, attracted by 
its negatively charged deoxyribonucleic acid (DNA) 
content [1-3]. 
 
Immunofluorescence antibody staining then results in 
fluorescence of the region around the nucleus that reveals 
the classic p-ANCA perinuclear pattern. The most frequent 
p-ANCA target is myeloperoxidase (MPO), a neutrophil 
granule protein whose primary role in classic metabolic 
processes is generation of oxygen radicals. ANCAs will, 
less commonly, form against alternative antigens, that may 
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also result in the p-ANCA pattern. These antigens include 
lactoferrin, elastase, and cathepsin G.  The presence of 
p-ANCAs is a sensitive, but not specific test for ulcerative 
colitis [1-3]. In contradistinction, c-ANCAs show a 
diffusely granular, cytoplasmic staining pattern. The 
c-ANCA pattern results from the binding of ANCAs to 
antigen targets throughout the neutrophil cytoplasm, and 
the most common protein targets at proteinase 3 (PR3). 
The PR3 c-ANCA pattern is often encountered in patients 
with Wegener's granulomatosis. Other antigens may also 
occasionally result in a c-ANCA pattern.  
 
Other types of ANCAs that develop against antigens other 
than myeloperoxidase or proteinase 3 will sporadically 
result in patchy staining when visualized by 
immunofluorescence [2]. The resultant pattern is 
commonly called the “snowdrift” prototype, and 
classically occurs in patients with non-vasculitic diseases 
that result in ANCA formation. It is not clear how these 
ANCAs are developed, although several hypotheses have 
been suggested. There is probably a genetic contribution 
(predominantly in genes controlling the level of the 
immune response); however, genetic susceptibility is 
likely to be linked to an environmental factor, as well as 
probable factors including vaccination or exposure to 
silicates [2].  
 
Case Report  
A 54-year-old female presented with a clinical history of a 
rapidly appearing, prutitic rash on her scalp, neck, hands, 
chest, abdomen, buttocks and back. A physical exam of the 
patient revealed an erythematous, macular rash in these 
areas, with lesions concentrated on the legs. The leg 
lesions included palpable purpura. No associated systemic 
symptoms were noted; lung and kidney function were 
within normal limits. No known concurrent medical 
conditions were present, and the patient was also not under 
treatment with any medications or herbal supplements. No 
paresthesias were present; urinary examination revealed 
no microhematuria or other abnormalities.  A punch 
biopsy of the skin was performed for hematoxylin and 
eosin (H & E) analysis, as well as for multicolor direct 
immunofluorescence (DIF) and for immunohistochemistry 
(IHC). 
 
Direct immunofluorescence (DIF): In brief, four um 
thickness skin cryosections were partially fixed in 3% 
paraformaldehyde, and then incubated with secondary 
antibodies, all conjugated with fluorescein isothiocyanate 
(FITC). The following anti-human rabbit antibodies were 
utilized: anti-human IgG (γ chain), anti-human IgA (α 
chain), anti-human IgM (μ-chain), anti-complement 3c, 
anti-fibrinogen, anti-albumin from (all at either 1:20 to 
1:40 dilutions; all from Dako, Carpinteria, California, 
USA).  In addition, we utilized goat anti-human 
IgE-antiserum, conjugated with FITC from Vector 
Laboratories, Bridgeport New Jersey, USA, as well as 
goat-anti-human complement C1q antiserum from 
Southern Biotech, Birmingham, Alabama, USA.  The 
slides were then counterstained with either 4', 
6-diamidino-2-phenylindole (DAPI) (Pierce, Rockford, 
Illinois, USA), or with the carbocyanine monomer 
TO-PRO-3 dye (Molecular Probes, Invitrogen, Carlsbad, 
California, USA), washed, and coverslipped.  The results 
are summarized in Fig. 1. 
 
Hematoxylin and Eosin (H&E) stain: The H&E staining 
displayed histologic features of mild, diffuse epidermal 
spongiosis, and a mild, superficial dermal inflammatory 
process involving capillaries and small venules. A mild, 
superficial, perivascular dermal infiltrate of lymphocytes, 
histiocytes and neutrophils was present, with perivascular 
leukocytoclastic debris and focal vascular fibrinoid 
necrosis also appreciated (Fig. 1). The H &E displayed 
other findings, including focal, perivascular extravasation 
of erythrocytes into the dermal interstitial tissue; 
occasional neutrophils were also noted to be present 
within the epidermal stratum spinosum (Fig. 1). Direct 
immunofluorescence (DIF) displayed the following results: 
anti-human IgG, IgA, and albumin (all++), and anti-human 
fibrinogen (+++) deposits were noted, all in a linear 
pattern along the BMZ, and surrounding the superficial 
dermal blood vessels. Significant p-ANCAs were positive 
within selected neutrophils when utilizing anti-human IgG, 
IgA and IgM. In addition, by DIF we detected the presence 
of autoreactivity to intracytoplasmic keratinocytes with 
FITC-conjugated anti human C1q (Fig. 1).  
 
 
Fig. 1 Presence of neutrophil extracellular traps and antineutrophil 
cytoplasmic antibodies associated with vasculitides using DIF and IHC.   
 
a through f, and i, DIF. a. Area of vasculitis, showing deposits of 
FITC-conjugated anti-human fibrinogen within dermal vessels (red 
arrows). b. Intra-cytoplasmic deposits of FITC-conjugated antihuman 
C1q within epidermal cells (red arrow). c. Positive p-ANCAs (yellow 
arrow) using FITC-conjugated anti-human IgG. The nuclei are 
counterstained in red with TO-PRO-3 dye (blue arrow); vessel 
autoreactivity is displayed in green utilizing the FITC-conjugated 
anti-human IgG (white arrow). d. Positive p-ANCAs (yellow arrows) in 
the dermis utilizing FITC-conjugated anti-human IgG antibodies. The 
nuclei are counterstained in red with TO-PRO-3 (blue arrows). e, Same 
as d, but at higher magnification, and without nuclear counterstaining. f. 
Shows a detail of the p-ANCA antigen(s) in the epidermis and the NETs 
(yellow arrows). g IHC staining with collagen IV shows strong reactivity 
to the BMZ, as well as around the superficial dermal vessels (brown stain) 
(aqua arrows). h. H & E staining demonstrating leukocytoclastic 
vasculitis with fibrinoid necrosis (blue arrow). .i, DIF, and g, deposits of 
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nuclear dust (yellow) on some superficial vessels utilizing 
FITC-conjugated anti-human IgA antibodies (yellow arrows). The blue 
arrows show the nuclei counterstained with TO-PRO-3. j An IHC stain 
using anti-CD34 on the vascular area in i, and showing strong, 
fragmented endothelial expression of this molecule (aqua arrows). k, IHC 
stain utilizing myeloperoxidase (red arrows). l. IHC CD31 antibody 
shows fragmented endothelial cells (red arrows).  
 
Immunohistochemistry (IHC): We performed IHC to 
confirm the DIF data, and to be able to distinguish 
between real, pathologic autoreactivity detected by direct 
immunofluorescence, versus non-pathologic, incidental 
autofluorescence of the dermal blood vessels. We 
performed IHC by using a dual endogenous peroxidase 
blockage, according to the Dako instructions, with the 
addition of an Envision dual link. We applied 3, 3 
diaminobenzidine (DAB) as a chromogen marker, and 
then counterstained with hematoxylin. The samples were 
run in a Dako Autostainer Universal Staining System. We 
stained for rabbit anti-human IgA, IgM, IgD, IgE, C1q, 
fibrinogen, albumin, and the blood vessel vascular 
endothelial antigens CD31 (PECAM) and CD 34; in 
addition, we utilized D2-40 to highlight dermal lymphatic 
vessel endothelia. Anti-myeloperoxidase (MPO) antibody 
from Dako was also utilized in the IHC studies.  Our tests 
confirmed the autoreactivity detected by DIF to the 
basement membrane zone (BMZ) area of the skin, as well 
as to the superficial and intermediate dermal vessels (Fig. 
2).  In addition, the IHC analysis revealed positive 
staining with myeloperoxidase (MPO) antibodies in the 
same areas where the p-ANCAs were observed in the 
epidermis and dermis by DIF.  The patient was treated 
immediately with topical corticosteroids, as well as with 
one injection of intramuscular steroids (60 mg IM).  One 
and a half weeks later, the patient was tested for 1) blood 
complement C3, and 2) an ANCA panel for vasculitis 
including myeloperoxidase (MPO), proteinase 3 
antibodies and immunoglobulin E antibodies. Each of 
these test parameters were reported within normal limits, 
and the clinical lesions exhibited clearance at this time. 
 
 
Fig. 2 Real immunoreactivity versus intrinsic, non-pathologic 
background immunoreactivity in the dermal blood vessels using IHC.  
 
Our results confirmed our previous DIF findings. In panel a, note 
fragmented positivity for CD 34 (red arrow). In b, autoreactivity to 
intermediate vessels using C1q (yellow arrows). c. Again using C1q, 1) 
an intracytoplasmic epidermal stratum spinosum reactivity is noted [(also 
shown with the DIF], as well as 2) a reactivity to the superficial plexus 
dermal vessels, and 3) to the intermediate dermal vessels (red arrows), 
(also IHC colocalized with both anti-CD31/PECAM and CD34 
antibodies). d. Interestingly, some of these vessels also demonstrated 
positive findings utilizing anti-human IgD (yellow arrows) e, (red 
arrows). In f, Dermal perivascular reactivity was also noted utilizing 
anti-IgE (yellow arrows) and utilizing IgA (data not shown). g. 
Autoreactivity to the vessels utilizing anti-IgM (yellow arrows), as well 
as in h, to IgG (red arrows). In (i) note positive autoreactivity to the basal 
BMZ area, and the superficial vascular plexus (yellow arrows), and, in j, 
to intermediate dermal vessels (blue arrows). Finally, in k and l, we note 
compartmentalization or “tight cuffing” of the observed in the 
inflammatory areas utilizing anti-human fibrinogen (red arrows), and 
anti-human albumin (blue arrows), respectively. 
 
Discussion 
Small-vessel vasculitides are autoimmune disorders, 
often associated with antineutrophil cytoplasmic 
autoantibodies (ANCAs) [1]. The c-ANCAs are 
detected serum testing, as well as by direct and indirect 
immunofluorescence in a number of autoimmune 
disorders [1]. ANCAs were originally divided into two 
primary classes, c-ANCAs and p-ANCAs, based on 
their pattern of staining in neutrophils. ANCA 
associated vasculitides classically affect the small 
vessels, and can present diverse clinical manifestations 
[1-3]. The primary clinical treatment of these disorders 
is systemic corticosteroid therapy, with or without other 
immunosuppressants.  
 
Attempts to explain and model the presence of ANCAs 
have included the theory of molecular mimicry. For 
instance, microbial superantigens are molecules expressed 
by bacteria and other microrganisms that have the power 
to stimulate a strong immune response by activation of T 
lymphocytes. These molecules generally have regions that 
resemble self-antigens; thus, the origin of the theory of 
molecular mimicry. Staphylococcal and streptococcal 
superantigens have been characterized in several 
autoimmune diseases. The classic example of such 
superantigen pathophysiology is found in group A 
Streptococcal rheumatic heart disease, where there is 
similarity between the M proteins of Streptococcus 
pyogenes and those of cardiac myosin and laminin. It has 
also been shown that up to 70% of patients with Wegener's 
granulomatosis are chronic nasal carriers of 
Staphylococcus aureus, with carriers having an eight times 
increased risk of disease presentation [3]. In addition, an 
alternative theory of defective apoptosis has been 
suggested as a possible explanation of ANCA 
pathophysiology.  Neutrophil apoptosis, or programmed 
cell death, is critical in controlling the duration of the early 
inflammatory response, thus reducing injury to normal 
tissues by the neutrophils. ANCAs may be developed 
secondary to either 1) ineffective apoptosis or 2) 
ineffective removal of apoptotic cell fragments, leading to 
the exposure of the immune system to molecules normally 
sequestered inside the cells. The apoptosis theory solves 
the seeming pathophysiologic contradiction of how it 
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could be possible for ANCAs to be raised against 
intracellular antigenic targets [3]. 
 
The role of ANCAs in disease has been linked to three 
primary diseases that are consistently associated with 
ANCAs. The most commonly associated disorders are 
Wegener's granulomatosis, microscopic polyangiitis and 
glomerulonephritis [4-8]. The antibodies are assumed to 
be involved in the generation and/or progression of the 
clinical lesions. Traditionally, c-ANCAs are associated 
with Wegener’s granulomatosis; p-ANCAs are associated 
with both microscopic polyangiitis and focal necrotizing 
and crescentic glomerulonephritis [4-8].  However, in 
recent years, ANCAs targeted against other autoantigens 
have been identified, including those involved in 
Churg-Strauss syndrome. Patients with a number of other 
diseases, such as ulcerative colitis and ankylosing 
spondylitis, will frequently display ANCAs as well [4-8]. 
However, in these cases, there is classically no associated 
vasculitis, and the ANCAs are thought to be incidental or 
epiphenomena rather than part of the primary disease itself. 
Churg-Strauss syndrome is associated with p-ANCAs 
directed against MPO [5]. It is unclear what the role of 
ANCAs may be Wegener’s granulomatosis, 
glomerulonephritis, and Churg Strauss syndrome; they 
may be markers of the diseases, or, alternatively, may play 
some part in the pathogenic process. In Wegener's 
granulomatosis, there is positive correlation between 
ANCA titer and disease activity; further, in vitro studies 
have shown that ANCAs cause activation of primed 
neutrophils and react with endothelial cells expressing 
PR3 [4-8]. ANCAs may thus act by causing release of 
lytic enzymes from the white blood cells, causing 
vasculitis in the nearby blood vessel walls. 
 
In our case, the clinical diagnosis of cutaneous vasculitis is 
supported by biopsy confirmation.  Within the biopsy, 
microscopic findings of acute vasculitis such as fibrinoid 
necrosis, chronic signs such as endarteritis obliterans, and 
distant chronic signs such as acellular scarring were 
identified. Our findings did not favor the diagnosis of 
microscopic polyangiitis due to the following: 1) no 
additional indicators of granulomatous inflammation were 
present (e.g., evidence of lung cavities or infiltrates 
present for over one month duration); and 2) no biopsy 
findings of either a) glomerulonephritis, nor b) 
involvement of more than one organ system existed (as 
documented by a biopsy or surrogate marker).  The 
patient was not taking any medications at the time of 
biopsy. By definition, ANCA related vasculitides are 
usually "pauci-immune", that is, they present few and 
weak vascular immunoreactants by DIF .However, for 
more than fifty years, dermatopathologists and 
immunodermatologists were utilizing only monochromatic 
FITC DIF, and not multicolor immunofluorescence as we 
did in our case. Thus, the sensitivity and specificity of our 
analysis is increased by utilizing these techniques. We also 
utilized IHC; this technique was employed to rule out 
nonpathologic, intense autofluorescence of the vessels (i.e., 
to be able to distinguish between real pathologic reactivity 
versus intrinsic self fluorescence of the vessels). 
Our case also displays acute findings, and highlights the 
difficulty of making a specific diagnosis of vasculitis 
(especially due to the presence of IgA, IgD, vascular 
deposits and p-ANCAs). Specifically, we believe our case 
may represent a brief, largely subclinical presentation of 
Henoch Schonlein purpura, or, alternatively, an 
ANCA-positive small vessel vasculitis, i.e., polyarteritis 
nodosa [10-12]. Other diseases where the combined, 
simultaneous findings of vasculitis and ANCAs can be 
found include Goodpasture's syndrome/anti-GBM-positive 
renal disease, and eleven per cent of cases of giant-cell 
arteritis. Other rare, less likely diseases that should be 
considered include Felty's syndrome, atypical pneumonia, 
post-Streptococcal glomerulonephritis, systemic lupus 
erythematosus, mixed connective tissue disease, and 
Wegener’s granulomatosis. Finally, it should be noted that 
many non-MPO p-ANCAs exist, including 1) those 
directed at other polycytoplasmic enzymes (elastase, 
lactoferrin, lactoperoxidase, lysozyme, azurocidin, or 
cathepsin G), as well as 2) ANAs, and 3) 
granulocyte-specific ANAs (GS-ANAs) [10-12]. Based on 
the clinical, histologic and DIF findings in our case, a 
complete ANCA panel was ordered for the patient. One of 
the primary clinical problems encountered when 
evaluating patients with vasculitis is the fact that patients 
often present during an acute flare of the disease process.  
 
It is thus difficult for us to compare our case to other 
studies regarding treatment of early small vessel vasculitis. 
Specifically, we found reports where early treatment of 
MPO-p-ANCA-associated small vessel vasculitis was felt 
to be crucial for the patient’s positive prognosis (patients 
were treated with oral corticosteroid and 
cyclophosphamide therapy, in conjunction with 
plasmapheresis) [10-12]. Notably, one of the major 
problems physicians have to face when treating patients 
with early or chronic phase vasculitis is that patients may 
not respond to standard therapy, or may require 
unacceptably high doses of steroids or 
immunosuppressants [10-13].  In our case, prompt 
medical intervention resulted in the clearance of the 
clinical as well as normalization of the laboratory findings 
in our patient.  Finally, specific predictors of treatment 
resistance and relapse of ANCA-associated small-vessel 
vasculitis have been recently described by utilizing clinical, 
pathologic and serologic predictors of treatment resistance 
and relapse in a community-based cohort of patients with 
ANCA-associated vasculitides [10-13].  The presence of 
IgD has been also reported in association with allergic 
vasculitis [14]. Finally, we were also were able to 
demonstrate evidence of the p-ANCA antigen(s) in the 
epidermis. These likely represent chromatin fibers, or 
so-called neutrophil extracellular traps (NETs), released by 
ANCA-stimulated neutrophils; these antigens may contain 
the targeted autoantigens PR3 and MPO [15]. We conclude 
that in these cases, early H&E and multicolor DIF 
diagnosis and rapid treatment (with systemic 
corticosteroid therapy, with or without other 
immunosuppressants) may contribute to both a favorable 
prognosis, and to a lack of lesional clinical recurrence. 
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